Search clinical trials for: Buprenorphine: Dosing Group

Total 15019 results

Purdue Pharma LP

Completed

Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain

Low Back Pain

United States
Purdue Pharma LP

Completed

Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee

Osteoarthritis

United States
Lifespan
University of Rhode Island

Completed

Medication Maintenance Therapy in Community Pharmacy Settings (MATPharm)

Opioid-use Disorder

United States
Assistance Publique - Hôpitaux de Paris
Fondation Friedlander

Completed

Learning Process of Fourth Year Medical Students During a Doctor-patient Relationship Training (APTHERA)

Undergraduate Medical Students' Learning Process in Doctor-patient Relationship Training

France
Taiwan Mundipharma Pharmaceuticals Ltd.
Chang Gung Memorial Hospital; Taipei Medical University Shuang Ho Hospital; Changhua...

Completed

Safety and Effectiveness of Transdermal Buprenorphine in Cancer Pain (SOOTHE)

Cancer

Taiwan
St. Louis University

Completed

Buprenorphine Dose Adjustments and Gestational Age

Neonatal Abstinence Syndrome
Purdue Pharma LP

Completed

Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain - a 28-week Extension Study

Chronic Nonmalignant Pain

United States
Purdue Pharma LP

Completed

Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BTDS) After Variable Application Site Rest Periods

Healthy

United States
University of California, Los Angeles
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Healthy Lifestyle Behavior Intervention for Latino Women

Cardiovascular Diseases

United States
Centre Hospitalier Universitaire de Nice

Not yet recruiting

Inorganic Pyrophosphate Homeostasis (PPi) in Pediatric Chronic Kidney Disease (PPi-DIA)

Pyrophosphate, Fetuin A, IL1, IL6, TNFalpha, Control

France
Centro Hospitalar do Tâmega e Sousa

Completed

Inflammatory Parameters as Predictive Factors for Complicated Appendicitis

Acute Appendicitis
Norwegian Centre for Ageing and Health
The Research Council of Norway

Completed

Person- Centred Care Among Nursing Home Patients With Dementia

Dementia | Agitation
UNICANCER

Recruiting

SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal Cancers (SURVEILLE-HPV)

Oropharynx Squamous Cell Carcinoma

France
NYU Langone Health
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Promoting Safe Use of Pediatric Liquid Medications

Medication Errors

United States
AstraZeneca

Completed

Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer. (PYRUS)

Metastatic Castrate-Resistant Prostate Cancer (mCRPC), | Efficacy, | Safety and Tolerability, | Pharmacokinetics, | Pharmacodynamics, | Tumour Response.

United Kingdom, United States
Gazi University

Active, not recruiting

Narrative Group Counseling and Psychological Resilience

Psychological Resilience

Turkey
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Withdrawn

Assessing Optimal XR-Buprenorphine Initiation Points in Jail

Opioid Use Disorder

United States
Istanbul University - Cerrahpasa (IUC)

Completed

The Effect of Light on Sleep Quality and Physiological Parameters in Individuals in Intensive Care Unit

Sleep | Light

Turkey
Astellas Pharma Global Development, Inc.
National Institute on Drug Abuse (NIDA)

Completed

A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use Disorder

Opioid Use Disorder

United States
PATH
London School of Hygiene and Tropical Medicine; Monash University; University... and other collaborators

Not yet recruiting

Assessing the Acceptability, Feasibility, Effectiveness and Cost-effectiveness of LADB

Opioid Dependence
BioDelivery Sciences International

Withdrawn

Evaluation of BEMA® Buprenorphine NX for Buprenorphine Induction of Opioid Dependent Subjects

Opioid Dependence

United States
BioDelivery Sciences International

Completed

An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects

Opioid Dependence

United States
Mundipharma Pharmaceuticals Sdn. Bhd.

Completed

Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity

Osteoarthritis | Rheumatoid Arthritis | Lower Back Pain | Joint Pain | Muscle Pain

Malaysia
Purdue Pharma LP

Terminated

Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase

Osteoarthritis

United States
Purdue Pharma LP

Terminated

Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015

Back Pain Lower Back Chronic

United States
US Department of Veterans Affairs
National Institute on Drug Abuse (NIDA); Reckitt and Colman

Completed

Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice

Opiate Dependence

United States
Purdue Pharma LP

Completed

The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.

Osteoarthritis

United States
University of Pittsburgh
National Institute on Aging (NIA)

Completed

Sleep, Hypertension, and Nocturia: a Multicomponent Approach for Comorbid Illnesses (SHyN)

Hypertension | Sleep Disturbance | Nocturia

United States
Radboud University Medical Center

Completed

Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease (MATADOR)

Allogeneic Stem Cell Transplant | Acute Myeloid Leucaemia | Myelo Dysplastic Syndrome | Acute Graft Versus Host Disease Grade II-IV

Netherlands, Belgium
Didier Jutras Aswad
Canadian Institutes of Health Research (CIHR)

Completed

A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse (OPTIMA)

Opioid Use Disorder

Canada
State University of New York at Buffalo
National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse...

Completed

Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients

Opiate Addiction

United States
Washington University School of Medicine

Recruiting

Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE) (Patch BRIDGE)

Pregnancy Complications | Pregnancy Related | Pregnancy, High Risk | Opioid Use Disorder | Buprenorphine Withdrawal

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department

Opiate Addiction

United States
University of Michigan

Completed

Character Strengths Intervention Among Psychiatrically Hospitalized Youth

Mental Disorders | Psychiatric Hospitalization | Child/Adolescent Problems
Idorsia Pharmaceuticals Ltd.

Completed

Single-ascending Oral Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-281959 / ACT-246475 in Healthy Male Subjects

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics

France
Yale University

Terminated

Project INSPIRE: INtervention Support Groups: Peers Inspiring Resilience and Empowerment

Domestic Violence

United States
AstraZeneca

Completed

Assessing the Pharmacokinetics of NKTR-118 in Subjects With Renal Impairment Compared to That in Subjects With Normal Renal Function

Renal Impairment

United States
Women and Infants Hospital of Rhode Island
National Institute of General Medical Sciences (NIGMS)

Withdrawn

Randomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrome (NOWS)

Neonatal Opioid Withdrawal Syndrome

United States
Titan Pharmaceuticals

Terminated

Study of Probuphine in Patients With Opioid Dependence (PRO-809)

Opioid Dependency

United States
National Institute on Drug Abuse (NIDA)
Alkermes, Inc.

Completed

Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults

Substance-Related Disorders

United States
Thomas Jefferson University

Completed

Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepines (MOPPlus)

Neonatal Abstinence Syndrome

United States
Johns Hopkins University

Recruiting

Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder (BIPOD-Out)

Opioid Use Disorder

United States
Indivior Inc.

Completed

Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection Locations

Opioid Use Disorder

United States
Albert Einstein College of Medicine
National Institute on Drug Abuse (NIDA); The City University of New York; Washington...

Completed

Pilot Test of a Community-based Buprenorphine Treatment Intervention

Opioid Dependence | Injection Drug Use

United States
Indivior Inc.

Completed

Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects

Opioid Related Disorder

United States
University of Pennsylvania
National Institute of Drug Abuse; The Wistar Institute; Ho Chi Minh City CDC; Institute...

Recruiting

Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1 (AMOHI-1)

Inflammation | Opioid-use Disorder | HIV-1-infection | Immune Activation | Buprenorphine | Methadone | Naltrexone | Antiretroviral Treatment

United States, Vietnam
Gwen McMillin

Completed

Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)

Bleeding | Venous Thromboembolism

United States
TC Erciyes University

Completed

Impact of Active Heating on Maternal and Neonatal Well-being

Hypothermia

Turkey
Assiut University

Unknown

Pancreatoduodenectomy With Mesopancreas Dissection.A Prospective Study Comparing Artery-first Approach Versus Standard Approach

Periampullary Carcinoma Resectable

Egypt
NYU Langone Health
Harvard Medical School (HMS and HSDM); National Institute on Drug Abuse (NIDA) and other collaborators

Recruiting

Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)

Opioid Use Disorder (OUD)

United States

Search clinical trials for: Buprenorphine: Dosing Group

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations